Animal drugs, feeds, and related products: Bimeda, Inc.,

[Federal Register: March 9, 2001 (Volume 66, Number 47)]

[Rules and Regulations]

[Page 14072-14074]

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

[DOCID:fr09mr01-3]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510, 520, 522, 524, 526, and 558

New Animal Drugs; Change of Sponsor

AGENCY: Food and Drug Administration

ACTION: Final rule.

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the change of sponsor for 25 approved new animal drug applications (NADA's) from Merial Ltd. to Bimeda, Inc.

DATES: This rule is effective March 9, 2001.

FOR FURTHER INFORMATION CONTACT: Norman J. Turner, Center for Veterinary Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-0214.

SUPPLEMENTARY INFORMATION: Merial Ltd., 2100 Ronson Rd., Iselin, NJ 08830-3077, has informed FDA that it has transferred ownership of, and all rights and interests in, the following approved NADA's to Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322.

Accordingly, the agency is amending the regulations in 21 CFR parts 510, 520, 522, 524, 526, and 558 to reflect the change of sponsor. The agency is also amending Sec. 510.60(c)(1) and (c)(2) to add the sponsor name and drug labeler code for Bimeda, Inc.

This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.'' Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.

List of Subjects

21 CFR Part 510

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

21 CFR Parts 520, 522, 524, and 526

Animal drugs.

21 CFR Part 558

Animal drugs, Animal feeds.

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510, 520, 522, 524, 526, and 558 are amended as follows:

[[Page 14073]]

PART 510--NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 510 continues to read as follows:

   Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

2. Section 510.600 is amended in the table in paragraph (c)(1) by alphabetically adding an entry for ``Bimeda, Inc.'' and in the table in paragraph (c)(2) by numerically adding an entry for ``061133'' to read as follows:

   Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.

   * * * * *

   (c) * * *

   (1) * * *

   Firm name and address

   Drug labeler code

   *

   *

   *

   * *

   *

   * Bimeda, Inc., 288 County Rd. 28, 061133 LeSueur, MN 56058-9322 *

   *

   *

   * *

   *

   *

   (2) * * *

   Drug labeler code

   Firm name and address

   *

   *

   *

   * *

   *

   * 061133

   Bimeda, Inc., 288 County Rd. 28, LeSueur, MN 56058-9322 *

   *

   *

   * *

   *

   *

   PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS

3. The authority citation for 21 CFR part 520 continues to read as follows:

   Authority: 21 U.S.C. 360b.

   Sec. 520.390a [Amended]

4. Section 520.390a Chloramphenicol tablets is amended in paragraph (b)(2) by removing ``050604'' and by adding in its place ``061133''.

   Sec. 520.540b [Amended]

5. Section 520.540b Dexamethasone tablets and boluses is amended in paragraph (b)(2) by removing ``050604'' and by adding in its place ``061133''.

   Sec. 520.622a [Amended]

6. Section 520.622a Diethylcarbamazine citrate tablets is amended in paragraph (a)(3) by removing ``050604'' and by adding in its place ``061133''.

   Sec. 520.622c [Amended]

7. Section 520.622c Diethylcarbamazine citrate chewable tablets is amended in paragraph (b)(4) by removing ``050604'' and by adding in its place ``061133''.

   Sec. 520.823 [Amended]

8. Section 522.823 Erythromycin phosphate is amended in paragraph (b) by removing ``050604'' and by adding in its place ``061133''.

   Sec. 520.1484 [Amended]

9. Section 520.1484 Neomycin sulfate soluble powder is amended in paragraph (b) by removing ``050604, and'' and by adding ``, and 061133'' after ``051259''.

   Sec. 520.1660d [Amended]

10. Section 520.1660d Oxytetracycline hydrochloride soluble powder is amended in paragraph (b)(7) by removing ``050604'' and by adding in its place ``061133''.

    Sec. 520.1696b [Amended]

11. Section 520.1696b Penicillin G potassium in drinking water is amended in paragraph (b) by removing ``050604, and'' and by adding ``, and 061133'' after ``053501''.

    Sec. 520.1720a [Amended]

12. Section 520.1720a Phenylbutazone tablets and boluses is amended in paragraph (b)(3) by removing ``and 059130'' and by adding in its place ``059130, and 061133''.

    Sec. 520.1720d [Amended]

13. Section 520.1720d Phenylbutazone gel is amended in paragraph (b) by removing ``050604'' and by adding in its place ``061133''.

    Sec. 520.2123a [Amended]

14. Section 520.2123a Spectinomycin dihydrochloride pentahydrate tablets is amended in paragraph (b), by removing ``050604'' and by adding in its place ``061133''.

    Sec. 520.2123b [Amended]

15. Section 520.2123b Spectinomycin dihydrochloride pentahydrate soluble powder is amended in paragraph (b) by removing ``050604'' and by adding in its place ``061133''.

    Sec. 520.2260b [Amended]

16. Section 520.2260b Sulfamethazine sustained-release boluses is amended in paragraphs (c)(1) and (e)(1) by removing ``050604'' and by adding in its place ``061133''.

    PART 522--IMPLANTATION OR INJECTABLE DOSAGE FORM NEW ANIMAL DRUGS

17. The authority citation for 21 CFR part 522 continues to read as follows:

    Authority: 21 U.S.C. 360b.

    Sec. 522.820 [Amended]

18. Section 522.820 Erythromycin injection is amended in paragraph (a) by removing ``050604'' and by adding its place ``061133''.

    Sec. 522.2444b [Amended]

19. Section 522.2444b Sodium thiopental, sodium pentobarbital for injection is amended in paragraph (b) by removing ``050604'' and by adding in its place ``061133''.

    [[Page 14074]]

    PART 524--OPHTHALMIC AND TOPICAL DOSAGE FORM NEW ANIMAL DRUGS

20. The authority citation for 21 CFR part 524 continues to read as follows:

    Authority: 21 U.S.C. 360b.

    Sec. 524.1580b [Amended]

21. Section 524.1580b Nitrofurazone ointment is amended in paragraph (b) by removing ``and 051259'' and by adding in its place ``051259, and 061133''.

    PART 526--INTRAMAMMARY DOSAGE FORMS

22. The authority citation for 21 CFR part 526 continues to read as follows:

    Authority: 21 U.S.C. 360b.

    Sec. 526.820 [Amended]

23. Section 526.820 Erythromycin is amended in paragraph (b) by removing ``050604'' and by adding in its place ``061133''.

    PART 558--NEW ANIMAL DRUGS FOR USE IN ANIMAL FEEDS

24. The authority citation for 21 CFR part 558 continues to read as follows:

    Authority: 21 U.S.C. 360b, 371.

    Sec. 558.58 [Amended]

25. Section 558.58 Amprolium and ethopabate is amended in the table in paragraph (d)(1), in item (iii), for the entry ``Arsanilic acid 90 (0.01pct) plus erythromycin 4.6 to 18.5'', under the ``Sponsor'' column by adding ``061133''.

26. Section 558.62 is amended by revising paragraph (a)(1), by adding paragraph (a)(3), and in the table in paragraph (c)(1) by redesignating entries (c)(1)(iii), (c)(1)(iv), and (c)(1)(v) as entries (c)(1)(iv), (c)(1)(vi), and (c)(1)(vii), respectively, and by adding new entries (c)(1)(iii) and (c)(1)(v) to read as follows:

    Sec. 558.62 Arsanilic acid.

    (a) * * *

    (1) To 015565: 20, 50, and 100 percent for use as in the table in paragraph (c)(1), entry (ii), item 1; entry (ii), item 2; entry (iv); entry (vi); and entry (vii) of this section.

    * * * * *

    (3) To 061133: 90 grams per pound arsanilic acid and 4.6 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (iii); 90 grams per pound arsanilic acid and 9.25 grams per pound erythromycin equivalents as erythromycin thiocyanate for use as in paragraph (c)(1), entry (v).

    * * * * *

    (c) * * *

    (1) * * *

    Arsanilic acid in Combination Indications for grams per in grams per

    use

    Limitations Sponsor

    ton

    ton

    *

    *

    *

    * *

    *

    * (iii) Erythromycin Chickens; growth As erythromycin 4.6

    promotion and thiocyanate; 012487 feed

    withdraw 5 days efficiency; before improving

    slaughter; as pigmentation. sole source of organic arsenic.

    *

    *

    *

    * *

    *

    * (v)

    Erythromycin Chickens; growth As erythromycin 9.25

    promotion and thiocyanate; 012487 feed

    withdraw 5 days efficiency; before improving

    slaughter; as pigmentation. sole source of organic arsenic. *

    *

    *

    * *

    *

    *

    * * * * *

    Sec. 558.248 [Amended]

27. Section 558.248 Erythromycin thiocyanate is amended in paragraphs (a)(1) and (a)(2) by removing ``050604'' and by adding in its place ``061133'', and in the table in paragraph (d)(1), in entries (i) through (vi), under the ``Sponsor'' column by removing ``050604'' wherever it appears and by adding in its place ``061133''.

    Sec. 558.625 [Amended]

28. Section 558.625 Tylosin is amended in paragraph (b)(39) by removing ``50604'' and by adding in its place ``061133''.

    Dated: January 29, 2001 Claire M. Lathers, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.

    [FR Doc. 01-5680Filed3-8-01; 8:45 am]

    BILLING CODE 4160-01-F